{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T06:27:40Z","timestamp":1781504860109,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Science, Technology & Innovation Funding Authority"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>We aimed to assess the efficacy of the injections of platelet rich plasma (PRP) for the treatment of severe dry eye disease (DED).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In this retrospecitve interventional clinincal study, we included 28 eyes of 14 patients with severe DED who were diagnosed with Sjogren syndrome. Each patient received unilateral lacrimal gland injection of PRP at days 0, 30, 60 and 90\u2009days while the other eye served as control group who received preservative free eye drops. We objectively assessed parameters at baseline, 1\u2009month, 2\u2009months and 3\u2009months including ocular surface analyzer (OSA) namely; noninvasive tear breakup times (NIBUT), tear meniscus height (TMH), lipid layer thickness (LLT) in addition to the Schirmer test I, corneal fluorescein staining (CFS) and meiboscore. The mean age was 43.4\u2009\u00b1\u2009.7.85\u2009years. Comparing different parameters, baseline data showed non-significant difference between injected eye group and control group. After 1 and 3 months of follow up, there were significant differences between both groups regarding NITBUT, TMH, LLT, CFS and Schirmer test, with <jats:italic>p<\/jats:italic>\u2009&lt;\u2009\u00a00.001 in favor of PRP group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Injection of PRP in lacrimal gland is simple, safe, and effective technique in treatment of severe dry eye; proved by improvement of tear film parameters through subjective and objective assessment. Further studies are needed to standardize the technique and to confirm these results.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-022-02554-0","type":"journal-article","created":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T14:02:49Z","timestamp":1660399369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Lacrimal gland injection of platelet rich plasma for treatment of severe dry eye: a comparative clinical study"],"prefix":"10.1186","volume":"22","author":[{"given":"Mai A.","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Y.","family":"Allam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Shafik","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihem","family":"Lazreg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Fahmy","family":"Doheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,13]]},"reference":[{"issue":"3","key":"2554_CR1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276\u201383.","journal-title":"Ocul Surf"},{"issue":"6","key":"2554_CR2","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/01.icu.0000143684.22362.46","volume":"15","author":"NG Anderson","year":"2004","unstructured":"Anderson NG, Regillo C. Ocular manifestations of graft versus host disease. Curr Opin Ophthalmol. 2004;15(6):503\u20137.","journal-title":"Curr Opin Ophthalmol"},{"issue":"2","key":"2554_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.blre.2013.02.001","volume":"27","author":"T Burnouf","year":"2013","unstructured":"Burnouf T, et al. Blood-derived biomaterials and platelet growth factors in regenerative medicine. Blood Rev. 2013;27(2):77\u201389.","journal-title":"Blood Rev"},{"issue":"13","key":"2554_CR4","first-page":"2045","volume":"46","author":"A Jaksche","year":"2005","unstructured":"Jaksche A, et al. Undiluted versus Diluted Autologous Serum Eye Drops (ASED): a prospective, randomized, double\u2013blind study in patients with refractory dry eye\u2013syndrome. Invest Ophthalmol Vis Sci. 2005;46(13):2045.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"2554_CR5","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/ICO.0000000000000271","volume":"33","author":"M Hussain","year":"2014","unstructured":"Hussain M, et al. Long-term use of autologous serum 50% eye drops for the treatment of dry eye disease. Cornea. 2014;33(12):1245\u201351.","journal-title":"Cornea"},{"issue":"2","key":"2554_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1053\/j.oto.2009.10.006","volume":"20","author":"AP Wroblewski","year":"2010","unstructured":"Wroblewski AP, Mejia HA, Wright VJ. Application of platelet-rich plasma to enhance tissue repair. Oper Tech Orthop. 2010;20(2):98\u2013105.","journal-title":"Oper Tech Orthop"},{"key":"2554_CR7","doi-asserted-by":"crossref","unstructured":"Anitua E, et al. Autologous serum and PRGF in ophthalmology: preclinical and clinical studies. Acta Ophthalmol. 2015;93(8):e605\u2013e614.\u00a0https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/aos.12710","DOI":"10.1111\/aos.12710"},{"issue":"5","key":"2554_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3109\/09537104.2016.1143922","volume":"27","author":"F Mussano","year":"2016","unstructured":"Mussano F, et al. Cytokine, chemokine, and growth factor profile of platelet-rich plasma. Platelets. 2016;27(5):467\u201371.","journal-title":"Platelets"},{"issue":"3","key":"2554_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000100933","volume":"39","author":"JL Alio","year":"2007","unstructured":"Alio JL, et al. Symptomatic dry eye treatment with autologous platelet-rich plasma. Ophthalmic Res. 2007;39(3):124\u20139.","journal-title":"Ophthalmic Res"},{"issue":"12","key":"2554_CR10","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1097\/ICO.0b013e31820d86d6","volume":"30","author":"S L\u00f3pez-Plandolit","year":"2011","unstructured":"L\u00f3pez-Plandolit S, et al. Efficacy of plasma rich in growth factors for the treatment of dry eye. Cornea. 2011;30(12):1312\u20137.","journal-title":"Cornea"},{"issue":"3","key":"2554_CR11","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/bjo.2005.080846","volume":"90","author":"P Tsai","year":"2006","unstructured":"Tsai P, et al. Proteomic analysis of human meibomian gland secretions. Br J Ophthalmol. 2006;90(3):372\u20137.","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"2554_CR12","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1097\/ICO.0000000000000449","volume":"34","author":"M Schargus","year":"2015","unstructured":"Schargus M, et al. Correlation of tear film osmolarity and 2 different MMP-9 tests with common dry eye tests in a cohort of non\u2013dry eye patients. Cornea. 2015;34(7):739\u201344.","journal-title":"Cornea"},{"issue":"10","key":"2554_CR13","first-page":"1442","volume":"24","author":"RA Thoft","year":"1983","unstructured":"Thoft RA, Friend J. The X, Y, Z hypothesis of corneal epithelial maintenance. Invest Ophthalmol Vis Sci. 1983;24(10):1442\u20133.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"2554_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/ICO.0000000000000016","volume":"33","author":"MY Avila","year":"2014","unstructured":"Avila MY. Restoration of human lacrimal function following platelet-rich plasma injection. Cornea. 2014;33(1):18\u201321.","journal-title":"Cornea"},{"key":"2554_CR15","unstructured":"Abdalrahman ARJA. Sub-conjunctival and lacrimal gland injection with platelet-rich plasma (E-PRP) in treating chronic unresponsive dry eye disease. ESCRS, Paris, France; 2019."},{"key":"2554_CR16","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"S Vital","year":"2002","unstructured":"Vital S. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis. 2002;61:554\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2554_CR17","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/09273940701486803","volume":"15","author":"F \u00d6zcura","year":"2007","unstructured":"\u00d6zcura F, Aydin S, Helvaci MR. Ocular surface disease index for the diagnosis of dry eye syndrome. Ocul Immunol Inflamm. 2007;15(5):389\u201393.","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"2554_CR18","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.ophtha.2007.06.031","volume":"115","author":"R Arita","year":"2008","unstructured":"Arita R, et al. Noncontact infrared Meibography to document age-related changes of the Meibomian glands in a Normal population. Ophthalmology. 2008;115(5):911\u20135.","journal-title":"Ophthalmology"},{"key":"2554_CR19","doi-asserted-by":"publisher","first-page":"S221","DOI":"10.1016\/S0039-6257(00)00201-0","volume":"45","author":"AJ Bron","year":"2001","unstructured":"Bron AJ. Diagnosis of dry eye. Surv Ophthalmol. 2001;45:S221\u20136.","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"2554_CR20","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1136\/bjophthalmol-2018-312072","volume":"103","author":"MY Avila","year":"2019","unstructured":"Avila MY, Igua AM, Mora AM. Randomised, prospective clinical trial of platelet-rich plasma injection in the management of severe dry eye. Br J Ophthalmol. 2019;103(5):648\u201353.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"2554_CR21","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.exer.2005.10.018","volume":"82","author":"D Zoukhri","year":"2006","unstructured":"Zoukhri D. Effect of inflammation on lacrimal gland function. Exp Eye Res. 2006;82(5):885\u201398.","journal-title":"Exp Eye Res"},{"issue":"1","key":"2554_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-015-0217-8","volume":"6","author":"M Tobita","year":"2015","unstructured":"Tobita M, Tajima S, Mizuno H. Adipose tissue-derived mesenchymal stem cells and platelet-rich plasma: stem cell transplantation methods that enhance stemness. Stem Cell Res Ther. 2015;6(1):1\u20137.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"2554_CR23","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s12015-013-9494-8","volume":"10","author":"MG Roubelakis","year":"2014","unstructured":"Roubelakis MG, et al. Platelet-rich plasma (PRP) promotes fetal mesenchymal stem\/stromal cell migration and wound healing process. Stem Cell Rev Rep. 2014;10(3):417\u201328.","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"2554_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.sjopt.2013.09.004","volume":"28","author":"S Tiwari","year":"2014","unstructured":"Tiwari S, Ali MJ, Vemuganti GK. Human lacrimal gland regeneration: perspectives and review of literature. Saudi J Ophthalmol. 2014;28(1):12\u20138.","journal-title":"Saudi J Ophthalmol"},{"issue":"3","key":"2554_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1076\/ceyr.19.3.201.5309","volume":"19","author":"SC Pflugfelder","year":"1999","unstructured":"Pflugfelder SC, et al. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sj\u00f6gren\u2019s syndrome keratoconjunctivitis sicca. Curr Eye Res. 1999;19(3):201\u201311.","journal-title":"Curr Eye Res"},{"issue":"4","key":"2554_CR26","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1097\/SLA.0b013e318211caf8","volume":"253","author":"R Matsuo","year":"2011","unstructured":"Matsuo R, Nakano Y, Ohkohchi N. Platelet administration via the portal vein promotes liver regeneration in rats after 70% hepatectomy. Ann Surg. 2011;253(4):759\u201363.","journal-title":"Ann Surg"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02554-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-022-02554-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02554-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T14:06:07Z","timestamp":1660399567000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-022-02554-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,13]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2554"],"URL":"https:\/\/doi.org\/10.1186\/s12886-022-02554-0","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,13]]},"assertion":[{"value":"28 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of Alexandria Faculty of Medicine ethics committee and with the 1964 Helsinki declaration and its later amendments. The ethical approval was obtained from the ethics committee of Alexandria Faculty of Medicine, Alexandria, Egypt. A written informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing financial issues.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"343"}}